Compare, Analyse Aventis Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TEVA PHARMA (Israel) - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   TEVA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
TEVA PHARMA
Dec-13
SANOFI INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,8402,961-   
Low Rs4,6302,573-   
Sales per share (Unadj.) Rs1,203.11,699.6-  
Earnings per share (Unadj.) Rs165.3106.2-  
Cash flow per share (Unadj.) Rs209.9243.6-  
Dividends per share (Unadj.) Rs84.0092.94-  
Dividend yield (eoy) %1.53.4 43.6%  
Book value per share (Unadj.) Rs963.61,888.0-  
Shares outstanding (eoy) m23.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.6 292.8%   
Avg P/E ratio x34.726.1 133.2%  
P/CF ratio (eoy) x27.311.4 240.5%  
Price / Book Value ratio x6.01.5 406.1%  
Dividend payout %50.887.5 58.1%   
Avg Mkt Cap Rs m132,0782,346,458 5.6%   
No. of employees `0003.344.9 7.3%   
Total wages/salary Rs m4,0680-   
Avg. sales/employee Rs Th8,393.832,067.6 26.2%   
Avg. wages/employee Rs Th1,232.40-   
Avg. net profit/employee Rs Th1,153.02,003.2 57.6%   
INCOME DATA
Net Sales Rs m27,7081,441,278 1.9%  
Other income Rs m8970-   
Total revenues Rs m28,6051,441,278 2.0%   
Gross profit Rs m6,235394,695 1.6%  
Depreciation Rs m1,027116,500 0.9%   
Interest Rs m728,309 0.0%   
Profit before tax Rs m6,098249,886 2.4%   
Minority Interest Rs m01,135 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,036 0.0%   
Tax Rs m2,292-3,051 -75.1%   
Profit after tax Rs m3,80690,036 4.2%  
Gross profit margin %22.527.4 82.2%  
Effective tax rate %37.6-1.2 -3,078.6%   
Net profit margin %13.76.2 219.9%  
BALANCE SHEET DATA
Current assets Rs m15,922973,434 1.6%   
Current liabilities Rs m6,235848,917 0.7%   
Net working cap to sales %35.08.6 404.7%  
Current ratio x2.61.1 222.7%  
Inventory Days Days6491 70.1%  
Debtors Days Days2196 21.8%  
Net fixed assets Rs m7,539470,753 1.6%   
Share capital Rs m2303,548 6.5%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,1921,600,987 1.4%   
Long term debt Rs m0736,958 0.0%   
Total assets Rs m29,8393,293,783 0.9%  
Interest coverage x872.19.8 8,874.9%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 212.2%   
Return on assets %12.83.6 355.7%  
Return on equity %17.25.6 305.0%  
Return on capital %27.54.9 557.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,739229,665 1.6%  
From Investments Rs m-731-81,380 0.9%  
From Financial Activity Rs m-1,972-275,499 0.7%  
Net Cashflow Rs m1,036-127,213 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare SANOFI INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SANOFI INDIA With: DR. REDDYS LAB  LUPIN  FULFORD INDIA  PANACEA BIOTECH  TORRENT PHARMA  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Related Views On News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 23, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - PFIZER COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS